Health ❯ Healthcare ❯ Clinical Trials ❯ Efficacy Studies

Patient Outcomes

Kodiak’s Zenkuda Hits Phase 3 Goal in Diabetic Retinopathy Prompting Faster FDA Filing

The results give Kodiak a clear path to a faster FDA filing.

FDA Approves First Glucocorticoid Receptor Blocker for Platinum-Resistant Ovarian Cancer